162PMonitoring of blood serum amyloid (SAA) to predict outcome of first-line pembrolizumab (P) in patients (pts) with advanced non-small cell lung cancer (ANSCLC)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 30; no. Supplement_2
Main Authors Di Noia, V, D’Argento, E, Vita, E, Ferrara, M, Damiano, P, Ribelli, M, Cannella, A, Virtuoso, A, Tortora, G, Bria, E
Format Journal Article
LanguageEnglish
Published Oxford University Press 01.04.2019
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdz063.060